Pınar ÇİMEN, Yelda VAROL, Ceyda MAHLEÇ ANAR, Hüseyin HALİLÇOLAR, Mehmet ÜNLÜ, Salih Zeki GÜÇLÜ

Sex-related differences in COPD Assessment Test scores of COPD populations with or without significant anxiety and/or depression

Background/aim: Sex-related differences have not been thoroughly explored in chronic obstructive pulmonary disease (COPD). We aimed to evaluate possible sex-related differences in COPD Assessment Test (CAT) scores of COPD patients with or without significant anxiety and/or depression. Materials and methods: Stable COPD patients were prospectively enrolled in the study between July 2013 and April 2014. Levels of anxiety, depression, dyspnea, and health-related quality of life parameters were assessed using specific questionnaires, including the CAT and others. Demographic and clinical data were recorded and physiological tests were performed. All the data were compared to determine any sex-related differences. Results: A total of 128 COPD patients (86 men, 42 women, mean age: 60.5 ± 9.3 years) were included. The women were significantly younger and had lower pack-years of cigarette smoking, and higher biomass smoke exposure, but displayed similarly severe COPD as compared to men. Beck anxiety (13.5 11) and Beck depression (15 11) inventory results were significantly higher in women than men (P = 0.04, P = 0.01). No statistically significant difference was found between the sexes in terms of CAT score, Modified Medical Research Council score, or COPD stage parameters (P > 0.05). Conclusion: Female patients have higher levels of depression and anxiety scores but present the same CAT scores related to COPD severity as compared to men.

PDF

___

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741-750.
2. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
3. van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 2009; 135: 368-377.
4. Camp PG, ODonnell DE, Postma DS. Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc 2009; 6: 535-538.
5. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54: 688-692.
6. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127: 1205-1211.
7. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys. Int J Methods Psychiatr Res 2003; 12: 3-21.
8. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, Labrecque M. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132: 148-155.
9. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J 2009; 34: 648-654.
10. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Barcelona, Spain: GOLD; 2011.
11. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. New York, NY, USA: ATS; 2002.
12. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
13. Yorgancıoğlu A, Polatlı M, Aydemir O, Yılmaz Demirci N, Kırkıl G, Naycı Atış S, Köktürk N, Uysal A, Akdemir SE, Özgür ES et al. Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks 2012; 60: 314-320 (in Turkish with abstract in English).
14. Fletcher CM. The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med 1952; 45: 577-584.
15. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnoea. Chest 1988; 93: 580-586.
16. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
17. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-897.
18. Ulusoy M, Sahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother 1998; 12: 163-172.
19. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
20. Guy W. Clinical Global Impressions: ECDEU Assessment Manual for Pharmacology, Revised Edition. Rockville, MD, USA: National Institute of Mental Health, Department of Health, Education, and Welfare Publication; 1976.
21. Hisli N. Beck Depresyon Envanterinin üniversite öğrencileri için geçerliği güvenirliği. Psikoloji Dergisi 1989; 23: 3-13 (in Turkish).
22. Tegin B. Depresyonda bilişsel bozukluklar: Beck modeline göre bir inceleme. PhD, Hacettepe University, Ankara, Turkey, 1980 (in Turkish).
23. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61: 1-117.
24. World Health Organization. World Health Statistics, 2008. Geneva, Switzerland: WHO; 2008.
25. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon, General-Executive Summary. Washington, DC, USA: U.S. Department of Health and Human Services; 2014.
26. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243-252.
27. Lopez Varela MV, Montes de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36: 1034-1041.
28. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
29. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA Jr. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005; 12: 1173-1179.